尚荣医疗收盘下跌1.04%，滚动市盈率144.43倍，总市值32.30亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Shangrong Medical, indicating a high PE ratio compared to industry averages [1][2] - As of July 22, Shangrong Medical's stock closed at 3.82 yuan, with a PE ratio of 144.43, significantly higher than the industry average of 53.47 [1] - The company has experienced a net outflow of 279.90 thousand yuan in principal funds on July 22, with a total outflow of 1,735.96 thousand yuan over the past five days [1] Group 2 - In the latest quarterly report for Q1 2025, the company reported revenue of 280 million yuan, a year-on-year increase of 130%, and a net profit of 13.96 million yuan, a year-on-year increase of 0.58% [2] - The company's gross profit margin stands at 15.27% [2] - Shangrong Medical is recognized as a national high-tech enterprise and has received numerous awards and honors, including over 180 patents, which contribute to its ongoing development [1]